Updates ·
Health notices · Thursday 24 September
3 notices from the agencies today, in plain words, each with the original linked.
Alfalfa sprouting seed recalled due to possible contamination
Centers for Disease Control and Prevention (CDC) · Food safety
If you bought or have alfalfa sprouting seed from Berlin Seeds, this CDC notice says it is being recalled because it may be contaminated with STEC and/or Salmonella.
STEC and Salmonella are types of bacteria that can cause foodborne illness.
Do not use the recalled seed; follow the recall steps in the CDC notice to reduce your risk.
What to do
- Do not use the recalled alfalfa sprouting seed.
FDA approval for RELUGOLIX to treat advanced prostate cancer
FDA · Approval
If you are an adult with advanced prostate cancer, the US Food and Drug Administration has approved RELUGOLIX (Orgovyx).
RELUGOLIX is a gonadotropin-releasing hormone (GnRH) receptor antagonist. A GnRH receptor antagonist is a medicine that blocks GnRH receptors.
This approval means your care team now has another option when treating advanced prostate cancer.
You can ask your clinician whether RELUGOLIX (Orgovyx) is appropriate for you.
What to do
- Ask your clinician whether RELUGOLIX (Orgovyx) is appropriate for you.
FDA approves dapagliflozin and metformin extended-release tablets
FDA · Approval
If you have type 2 diabetes, the FDA has approved dapagliflozin with metformin as extended-release tablets, to be used along with diet and exercise to improve glycemic control.
Dapagliflozin in this combination is also intended to help lower the risk of certain kidney outcomes and cardiovascular problems in specific adult groups described on the label.
No use for type 1 diabetes is recommended, and it is limited to people with type 2 diabetes for the listed indications.